Testing effectiveness (Phase 2)Study completedNCT02582775
What this trial is testing
MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
Who this might be right for
Epidermolysis Bullosa
Masonic Cancer Center, University of Minnesota 17